Keď je primárna rakovina pečene spojená s ascitom, žltačkou, vzdialenými metastázami atď., nazýva sa to pokročilá primárna rakovina pečene. Liečba pokročilého primárneho karcinómu pečene je náročná a klinický liečebný efekt nie je ideálny. Chirurgia nie je možnosťou na liečbu pokročilého karcinómu pečene, pretože sa rozšírila do lymfatických uzlín alebo iných orgánov.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the imunoterapia drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced rakovina pečene. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
